Rush University Medical Center is conducting the nation's first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or degenerative diseases such as osteoarthritis.
Jan 24, 2013
0
0
Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue. However, to function properly, the cells must often ...
Jan 10, 2013
0
0
Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging. An innovative delivery approach that dramatically increases the ...
Dec 21, 2012
0
0
UT Arlington engineers working with Army surgeons are developing a pliable, polymer mask embedded with electrical, mechanical and biological components that can speed healing from disfiguring facial burns and help rebuild ...
Jan 25, 2012
0
0
A clinical trial has established the non-inferiority of a drug-eluting stent with a bioabsorbable polymer compared to a drug-eluting stent with a durable polymer. Results of the EVOLVE clinical trial were presented today ...
Nov 11, 2011
0
0
